Keywords: NEDA, disease activity, relapse, disability progression, MRI activity Background No evidence of disease activity (NEDA; defined as no 12-week confirmed disability progression, no protocol-defined relapses, no new/enlarging T2 lesions and no T1 gadolinium enhancing lesions) using a fixed-study entry baseline is commonly used as a treatment outcome in multiple sclerosis (MS). Objective...
Pro zobrazení tohoto obsahu je třeba být přihlášen.